Saturday, August 22, 2026
ExploreSearch
Via News
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Platforms Rush to Establish Content-Authenticity Standards Amid Leadership Shakeups and Sustained Capex
Within days of each other in mid-August 2026, Google, Anthropic, and Spotify moved to formalize AI content watermarking and labeling policies, signaling an industry-wide push toward self-governed provenance standards as generative AI output floods consumer platforms. The shift coincides with executive turnover at OpenAI (Brad Lightcap's departure) and Meta's public AI manifesto, all set against continued heavy AI infrastructure capital expenditure and finance-sector moves (e.g., Wall Street paying for algorithmic edges on social signals) that underscore AI's deepening entanglement with capital markets.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts report JPMorgan Chase & Co.'s revenue for the same fiscal period (FY 2025) with the same observation date (2025-12-31), but with different values: $182.447 billion vs. $185 billion. The ~1.4% difference ($2.553 billion) is too large to be explained by rounding alone and represents conflicting data for the identical time period.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,977
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,977 facts checked against source5,242 source documents archived
Work with this data → vianewsagency.com
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 5, 2026

Merck (MRK) Up 1.7% Since Last Earnings Report: Can It Continue?

View original at finance.yahoo.com
Merck (MRK) Up 1.7% Since Last Earnings Report: Can It Continue? A month has gone by since the last earnings report for Merck (MRK). Shares have added about 1.7% in that time frame, outperforming the S&P 500…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Roche Holding has a Zacks Rank #3 (Hold)

    80% confidence

  • Generic competition for Januvia/Janumet, Bridion and Dificid is expected to hurt revenues by approximately $2.5 billion in 2026

    80% confidence

  • The estimate of $70 billion was $20 billion more than its previous estimate a year ago

    80% confidence

  • The estimate of $70 billion was more than double the peak consensus estimate for Keytruda revenues of $35 billion in 2028

    80% confidence

  • Keytruda growth was negatively impacted by approximately $200 million due to the unfavorable timing of wholesaler purchases in the United States in Q4 2025

    80% confidence

  • Adjusted earnings per share are expected to be between $5.00 and $5.15 in 2026

    80% confidence

  • In 2026, Merck expects to buy back shares worth $3 billion

    80% confidence

  • Merck has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months

    80% confidence

  • Merck expects revenues to be in the range of $65.5-$67.0 billion in 2026, representing year-over-year growth of 1% to 3%

    80% confidence

  • A lower-than-expected infant immunization rate and high inventory levels in the market hurt Enflonsia sales in Q4 2025

    80% confidence

  • Merck expects over $70 billion of potential non-risk-adjusted commercial opportunity for the current pipeline by the mid-2030s

    80% confidence

  • The adjusted gross margin is expected to be around 82% in 2026

    80% confidence
Merck (MRK) Up 1.7% Since Last Earnings Report: Can It Continue? — Source | Via News | ViaNews Market